Literature DB >> 30095778

Balloon Uterine Tamponade Device After Peripartum Hysterectomy for Morbidly Adherent Placenta.

Ashten Waks1, Kareem Tabsh, Khalil Tabsh, Yalda Afshar.   

Abstract

BACKGROUND: Perioperative hemorrhage is a common complication of peripartum hysterectomy for morbidly adherent placenta. We present an application of a balloon uterine tamponade device in the setting of a cesarean delivery and subsequent supracervical hysterectomy for abnormal placentation. CASE: A 33-year-old gravid woman, 6 para 3022, at 33 2/7 weeks of gestation was admitted in preterm labor, with placenta previa and suspected morbidly adherent placenta, for a planned cesarean delivery and hysterectomy. After supracervical hysterectomy, colloid resuscitation and packing failed to provide hemostasis. A transcervical balloon uterine tamponade device subsequently was placed intraperitoneally and left on tension owing to the need for further tamponade.
CONCLUSION: Use of a balloon uterine tamponade device intraperitoneally posthysterectomy was associated with hemorrhage control. This application may facilitate timely management and streamlining of obstetric resources for postpartum hemorrhage.

Entities:  

Mesh:

Year:  2018        PMID: 30095778     DOI: 10.1097/AOG.0000000000002792

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  2 in total

1.  Efficacy of intrauterine Bakri balloon tamponade combined with ascending uterine artery ligation on postpartum hemorrhage.

Authors:  Guangna Ma; Li Gao; Qinwen Li; Xudong Zhao
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  Horizontal Cervix as a Novel Sign for Predicting Adhesions on the Posterior Extrauterine Wall in Cases of Placenta Previa.

Authors:  Shinya Matsuzaki; Aiko Okada; Masayuki Endo; Yoshikazu Nagase; Satoshi Nakagawa; Kosuke Hiramatsu; Aiko Kakigano; Kazuya Mimura; Tsuyoshi Takiuchi; Takuji Tomimatsu; Yutaka Ueda; Kazuhide Ogita; Tadashi Kimura
Journal:  J Clin Med       Date:  2019-12-04       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.